Pharmacology for Nurses · Gastrointestinal Disorder Drugs
Antiemetics
On this page 9 sections
In 30 seconds
Nausea and vomiting are not diseases — they are symptoms with many possible causes, and the body's vomiting machinery is the same no matter what triggers it. The Vomiting center The medullary neurons that coordinate the act of vomiting Full entry →, a group of neurons in the medulla, coordinates the act of vomiting: it sends signals that contract the diaphragm and abdominal muscles, close the airway, and empty the stomach. The vomiting center is activated by four main inputs: the Chemoreceptor trigger zone (CTZ) A brain region outside the blood–brain barrier that detects toxins and drugs in blood Full entry →, a specialized area near the base of the brain that senses toxins and drugs in the blood (it sits outside the blood–brain barrier, so it can sample blood freely); the Vestibular system The inner-ear balance system Full entry →, which senses motion and balance; the GI tract itself, whose nerve endings send distress signals (irritation, stretch, inflammation); and higher brain centers, which respond to sights, smells, memories, and anxiety.
Antiemetics are drugs that interrupt this pathway. Each class blocks a specific receptor somewhere along the line — serotonin (5-HT3) receptors at the CTZ and gut, dopamine (D2) receptors at the CTZ, histamine (H1) and muscarinic receptors in the vestibular system, and neurokinin-1 (NK1) receptors in the vomiting center. Because different causes of nausea travel different pathways, choosing the right antiemetic means matching the drug's mechanism to the cause: chemotherapy nausea is mostly a CTZ/5-HT3 story, motion sickness a vestibular/H1-and-muscarinic story, and postoperative nausea a mix of anesthesia, pain, and GI inputs.
Why this matters
Vomiting is common, miserable, and sometimes dangerous. It can cause dehydration and electrolyte loss, interfere with nutrition and oral medications, and lead to aspiration — especially in older adults, people with altered consciousness, and infants. Antiemetics are used across nearly every clinical setting: after surgery (postoperative nausea and vomiting, or PONV), with chemotherapy and radiation, in gastroenteritis, in pregnancy-related nausea (hyperemesis gravidarum), in motion sickness, and in people taking opioids or other drugs that trigger nausea. For the nurse, antiemetics matter three ways: assessment (what is causing the nausea? what does the vomitus look like? is the person dehydrated?), administration and monitoring (many antiemetics cause sedation or dizziness, raising fall risk; some have cardiac effects), and teaching (non-drug measures, when to call, what to expect). Exam questions love mechanism matching: given the cause of vomiting, which antiemetic class is the best fit?
The college version
Core Concepts
The vomiting pathway: inputs to the vomiting center
The vomiting center integrates signals and coordinates the physical act. Each input has its own receptors, which is why each antiemetic class has a niche:
- CTZ — samples blood for toxins, drugs (e.g., chemotherapy, opioids, digoxin), and metabolic abnormalities. Rich in 5-HT3 (serotonin) and D2 (dopamine) receptors.
- Vestibular system — detects motion and sends signals through pathways rich in H1 (histamine) and muscarinic (M1) receptors. This is why motion sickness responds to antihistamines and anticholinergics, not to the CTZ-targeting drugs.
- GI tract — irritation, stretch, or inflammation in the gut activates vagal afferents carrying 5-HT3 signals; chemotherapy damages intestinal cells, which release huge amounts of serotonin.
- Higher centers — anticipation, anxiety, smells, and memories (relevant in Anticipatory nausea Nausea conditioned by past chemotherapy experiences Full entry → before chemotherapy) involve cortical input that some anxiolytics and behavioral measures address.
5-HT3 receptor antagonists: the chemotherapy and postoperative mainstays
5-HT3 antagonists (prototype: ondansetron) block serotonin receptors in the CTZ and on vagal nerve endings in the gut. They are highly effective for chemotherapy-induced nausea and vomiting, radiation-induced nausea, and postoperative nausea, because those triggers are driven by serotonin release. They are generally well tolerated, with headache and constipation among the more common effects; some carry QT-interval cautions, so cardiac risk is assessed per current references. They do not work well for motion sickness, because the vestibular pathway is not serotonin-driven — a classic mechanism-matching point.
NK-1 receptor antagonists: for highly emetogenic chemotherapy
NK-1 antagonists (prototype: aprepitant) block substance P at neurokinin-1 receptors in the vomiting center. Substance P is a key player in the delayed phase of chemotherapy-induced nausea. NK-1 antagonists are typically used as part of combination regimens for highly emetogenic chemotherapy rather than as a single agent — verify the specific regimen against current guidelines and orders.
Dopamine (D2) antagonists: broad but with caution
Drugs that block dopamine D2 receptors in the CTZ — including phenothiazines (prototype: prochlorperazine) and related agents — are effective for many causes of nausea, including drug-induced and postoperative nausea. Metoclopramide is a D2 antagonist with an additional effect: it speeds gastric emptying (a Prokinetic A drug that speeds stomach emptying Full entry →), which makes it useful when nausea is linked to delayed stomach emptying. D2 blockade can cause Extrapyramidal symptoms Movement problems from dopamine blockade (restlessness, spasms, rigidity) Full entry → — restlessness, muscle spasms, or parkinsonian-like movements — and sedation, so patients are monitored and educated, and these effects are reported promptly.
Antihistamines and anticholinergics: the motion-sickness drugs
Antihistamines (H1 blockers, prototype: dimenhydrinate/meclizine) and anticholinergics (prototype: scopolamine) block the vestibular pathway, making them the drugs of choice for motion sickness and vestibular disorders. Their mechanism also explains their adverse effects: histamine and muscarinic blockade cause sedation and dry mouth, and anticholinergics are used cautiously in older adults because of confusion, urinary retention, and other anticholinergic risks. These drugs are taken before the motion begins — once vomiting is underway, an oral tablet may not stay down.
Corticosteroids and other adjuncts
Corticosteroids (e.g., dexamethasone) have antiemetic effects that are not fully understood but are used as adjuncts in chemotherapy regimens to enhance the effect of the primary antiemetic. Cannabinoids (dronabinol) are used in some chemotherapy-related nausea that does not respond to standard therapy, with sedation and psychotropic effects that limit their use. Benzodiazepines help mainly with anticipatory nausea — the conditioned nausea some people experience before a chemotherapy session — by reducing anxiety; they are not primary antiemetics.
Nursing care of the person with nausea and vomiting
Assessment comes first: what triggered it, how long it has lasted, what the vomitus looks like (food, bile, blood — bright red or coffee-ground), how much has been lost, and whether the person shows signs of dehydration or electrolyte imbalance. Hydration and safety are priorities: monitor intake and output, offer fluids as tolerated per orders, and watch for falls — many antiemetics cause dizziness and sedation. Non-drug measures nurses teach include small frequent meals, avoiding strong odors, and cool, quiet environments; for motion sickness, lying still and looking at a fixed point help. Route matters: a person who is actively vomiting may need the drug by a non-oral route (per orders), and an antiemetic given before chemotherapy should be timed per the protocol. Scope note: choosing and dosing antiemetics, including combination antiemetic regimens for chemotherapy, requires prescriber orders and follows current guidelines, the facility formulary, and institutional policy; assessment, monitoring, education, and safety measures are core nursing work. Always verify indications, routes, monitoring, and precautions against current references, the formulary, and prescriber orders.
Common Confusions
| Do Not Confuse | With | Difference |
|---|---|---|
| The CTZ | The vomiting center | The CTZ senses blood-borne triggers and sits outside the blood–brain barrier; the vomiting center coordinates the act of vomiting itself |
| Motion-sickness drugs | Chemotherapy antiemetics | Antihistamines/anticholinergics block the vestibular pathway; 5-HT3 antagonists block the CTZ/gut serotonin pathway. Using the wrong class for the cause fails |
| Anticipatory nausea | Chemotherapy-induced nausea | Anticipatory nausea is conditioned by past experiences and responds to anxiety management; chemotherapy nausea is a direct drug effect needing 5-HT3/NK-1 blockade |
| Metoclopramide's prokinetic effect | A purely antiemetic effect | It blocks D2 in the CTZ AND speeds gastric emptying; both matter in choosing it |
| Nausea | Retching/vomiting | Nausea is the urge; retching is the muscle effort without expulsion; vomiting is expulsion. A patient can have one without the other, and assessment separates them |
| "One antiemetic fits all" | Cause-matched selection | Each class blocks one input pathway; severe or chemo-related nausea often needs combination regimens per guidelines |
| Sedation from antiemetics | "Just a side effect" | Sedation and dizziness raise fall risk — a nursing priority, especially in older adults and after surgery |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Your brain has a "throw-up button" — a place that makes your belly squeeze and empty when it gets bad news. Different kinds of bad news travel different roads to reach that button: poison and strong medicine come through one road, a bumpy car ride comes through another, and a yucky smell comes through a third. Antiemetics are like roadblocks: each one blocks a different road, so doctors pick the medicine that blocks the road your nausea is coming from.
Worked example
Ms. Okafor, age 45, is about to receive her first cycle of chemotherapy known to cause severe nausea. The nurse reviews the ordered antiemetic regimen with her: a 5-HT3 antagonist is scheduled before the infusion, because chemotherapy damages intestinal cells that release serotonin — the signal the drug blocks. The nurse explains the timing, tells her that an NK-1 antagonist is part of the regimen to cover the delayed nausea over the next days, and reviews non-drug measures: small frequent meals, bland foods, avoiding strong cooking smells, and calling if she cannot keep fluids down. Before administering, the nurse checks her cardiac history because the 5-HT3 antagonist carries a QT-interval caution, and verifies the order against the formulary. Later that evening, Ms. Okafor reports feeling restless and unable to sit still; the nurse recognizes this could be an extrapyramidal effect from a dopamine-blocking drug she also received, reports it promptly, and implements fall precautions. The teaching point: the nurse matched each drug to the physiology it targets, taught the patient what to expect, and acted fast when an adverse effect appeared.
Key takeaways
- The vomiting center coordinates vomiting; it is driven by the CTZ (blood-borne triggers), vestibular system (motion), GI tract (irritation), and higher centers (anticipation).
- Match mechanism to cause: 5-HT3 antagonists → chemotherapy/radiation/postoperative; antihistamines/anticholinergics → motion sickness; NK-1 antagonists → delayed chemotherapy nausea; D2 antagonists → broad use, including drug-induced nausea.
- 5-HT3 antagonists (e.g., ondansetron) are mainstays for chemo and PONV; some carry QT-interval cautions.
- D2 antagonists can cause extrapyramidal symptoms — restlessness, spasms, abnormal movements — report promptly.
- Antihistamine/anticholinergic antiemetics cause sedation and dry mouth; anticholinergics are used cautiously in older adults.
- Motion-sickness drugs work best taken before motion begins — prevention beats treatment once vomiting starts.
- Vomiting risks: dehydration, electrolyte loss, aspiration, and falls (drug-induced sedation/dizziness).
- Assess the vomitus (food, bile, bright red or coffee-ground blood) — it is clinical information, not just mess.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
Name the four main inputs to the vomiting center and one antiemetic class that targets each.
Show answer
CTZ (5-HT3 and D2 antagonists), vestibular system (antihistamines, anticholinergics), GI tract (5-HT3 antagonists acting on gut nerves), and higher centers (benzodiazepines/behavioral measures for anticipatory nausea).
Why does ondansetron work well for chemotherapy nausea but poorly for motion sickness?
Show answer
Because chemotherapy nausea is driven by serotonin released in the gut and sensed at the CTZ — ondansetron blocks 5-HT3 receptors there. Motion sickness travels the vestibular pathway, which does not rely on serotonin.
What is the CTZ, and why is it able to sense blood-borne triggers?
Show answer
The CTZ is a brain region outside the blood–brain barrier, so it can sample blood directly for toxins, drugs, and metabolic abnormalities and activate the vomiting center in response.
A patient receiving a dopamine-blocking antiemetic reports restlessness and muscle spasms. What is happening, and what should the nurse do?
Show answer
These are likely extrapyramidal symptoms from dopamine blockade. The nurse should report promptly, monitor, implement safety measures (including fall precautions), and follow the prescriber's direction.
Why are antihistamine/anticholinergic antiemetics best taken before motion begins?
Show answer
Because they block the vestibular pathway and work best before the motion stimulus builds up; once vomiting is underway, an oral dose may not be absorbed or stay down.
What are the three main dangers of vomiting that nursing care addresses?
Show answer
Dehydration and electrolyte loss, aspiration of vomitus into the lungs, and falls from sedation/dizziness — addressed with hydration monitoring, airway protection, and safety precautions.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Vomiting center
- The medullary neurons that coordinate the act of vomiting
- Chemoreceptor trigger zone (CTZ)
- A brain region outside the blood–brain barrier that detects toxins and drugs in blood
- 5-HT3 receptor
- A serotonin receptor on the CTZ and gut nerves
- NK-1 receptor
- A receptor for substance P in the vomiting center
- Vestibular system
- The inner-ear balance system
- Extrapyramidal symptoms
- Movement problems from dopamine blockade (restlessness, spasms, rigidity)
- Prokinetic
- A drug that speeds stomach emptying
- Anticipatory nausea
- Nausea conditioned by past chemotherapy experiences
- Emesis
- The act of vomiting
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.